John P. Schmid insider trades
Open-market stock purchases and sales by John P. Schmid, Unknown at BlossomHill Therapeutics, Inc, from SEC Form 4 filings since Nov 3, 2010.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +203%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc | Bought | $96K |
| Jun 15, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Jun 15, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Jun 9, 2026 | DSGN Design Therapeutics, Inc | Bought (not open market) | — |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
Companies traded
- BLSM BlossomHill Therapeutics, Inc: 1 buy, last Aug 10, 2026
- TRAX First Tracks Biotherapeutics, Inc: other filings, last Jun 15, 2026
- ANAB Anaptysbio, Inc: 3 sales, last Jun 15, 2026
- DSGN Design Therapeutics, Inc: 2 buys, last Jun 9, 2026
- BBOT BridgeBio Oncology Therapeutics, Inc: other filings, last Aug 11, 2025
- PSTX Poseida Therapeutics, Inc: other filings, last Jan 8, 2025
- XERS Xeris Biopharma Holdings, Inc: 5 buys, last Aug 12, 2024
- NEOS Neos Therapeutics, Inc: other filings, last Mar 19, 2021
- ASPX Auspex Pharmaceuticals, Inc: other filings, last May 5, 2015
- TSRX Trius Therapeutics Inc: 22 sales, last Sep 11, 2013